Targeting Insulin-Degrading Enzyme in Insulin Clearance
© 2021 by the authors.
| Autores: | , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/241744 |
| Acceso en línea: | http://hdl.handle.net/10261/241744 |
| Access Level: | acceso abierto |
| Palabra clave: | Insulin-degrading enzyme Insulin clearance Liver Pharmacological inhibitors Insulin resistance |
| id |
ES_d6bc861f2f2b6e35ffb3a40e00cf7df9 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/241744 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Targeting Insulin-Degrading Enzyme in Insulin ClearanceLeissring, Malcolm A.González-Casimiro, Carlos M.Merino, BeatrizSuire, Caitlin N.Perdomo, GermánInsulin-degrading enzymeInsulin clearanceLiverPharmacological inhibitorsInsulin resistance© 2021 by the authors.Hepatic insulin clearance, a physiological process that in response to nutritional cues clears ~50–80% of circulating insulin, is emerging as an important factor in our understanding of the pathogenesis of type 2 diabetes mellitus (T2DM). Insulin-degrading enzyme (IDE) is a highly conserved Zn2+-metalloprotease that degrades insulin and several other intermediate-size peptides. Both, insulin clearance and IDE activity are reduced in diabetic patients, albeit the cause-effect relationship in humans remains unproven. Because historically IDE has been proposed as the main enzyme involved in insulin degradation, efforts in the development of IDE inhibitors as therapeutics in diabetic patients has attracted attention during the last decades. In this review, we retrace the path from Mirsky’s seminal discovery of IDE to the present, highlighting the pros and cons of the development of IDE inhibitors as a pharmacological approach to treating diabetic patients.This research was funded by the Ministerio de Economía, Industria y Competitividad, grant number SAF2016-77871-C2-2-R to G.P.; Ministerio de Ciencia e Innovación PID2019-110496RB-C22 to G.P.; European Foundation for the Study of Diabetes (European Diabetes Research Programme on New Targets for Type 2 Diabetes supported by MSD-2017) to G.P.; European Foundation for the Study of Diabetes (EFSD) -Novo Nordisk to B.M.; and the US National Institutes of Health (GM115617) to M.A.L. The project leading to these results has received funding from “La Caixa” Foundation, under agreement LCF/PR/PR18/51130007 to G.P. C.M.G.-C. was supported by a fellowship from the Junta de Castilla y León and the European Social Fund (ORDER EDU/574/2018). B.M. was supported by a “Rising Star” fellowship (EFSD-Novo Nordisk).Multidisciplinary Digital Publishing InstituteMinisterio de Economía y Competitividad (España)Ministerio de Ciencia, Innovación y Universidades (España)Agencia Estatal de Investigación (España)European Foundation for the Study of DiabetesNovo NordiskNational Institutes of Health (US)Fundación la CaixaJunta de Castilla y LeónConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]2021202120212021info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_dcae04bcPublisher's versioninfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10261/241744reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2016-77871-C2-2-Rinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-110496RB-C22PID2019-110496RB-C22/AEI/10.13039/501100011033http://dx.doi.org/10.3390/ijms22052235Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/2417442026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Targeting Insulin-Degrading Enzyme in Insulin Clearance |
| title |
Targeting Insulin-Degrading Enzyme in Insulin Clearance |
| spellingShingle |
Targeting Insulin-Degrading Enzyme in Insulin Clearance Leissring, Malcolm A. Insulin-degrading enzyme Insulin clearance Liver Pharmacological inhibitors Insulin resistance |
| title_short |
Targeting Insulin-Degrading Enzyme in Insulin Clearance |
| title_full |
Targeting Insulin-Degrading Enzyme in Insulin Clearance |
| title_fullStr |
Targeting Insulin-Degrading Enzyme in Insulin Clearance |
| title_full_unstemmed |
Targeting Insulin-Degrading Enzyme in Insulin Clearance |
| title_sort |
Targeting Insulin-Degrading Enzyme in Insulin Clearance |
| dc.creator.none.fl_str_mv |
Leissring, Malcolm A. González-Casimiro, Carlos M. Merino, Beatriz Suire, Caitlin N. Perdomo, Germán |
| author |
Leissring, Malcolm A. |
| author_facet |
Leissring, Malcolm A. González-Casimiro, Carlos M. Merino, Beatriz Suire, Caitlin N. Perdomo, Germán |
| author_role |
author |
| author2 |
González-Casimiro, Carlos M. Merino, Beatriz Suire, Caitlin N. Perdomo, Germán |
| author2_role |
author author author author |
| dc.contributor.none.fl_str_mv |
Ministerio de Economía y Competitividad (España) Ministerio de Ciencia, Innovación y Universidades (España) Agencia Estatal de Investigación (España) European Foundation for the Study of Diabetes Novo Nordisk National Institutes of Health (US) Fundación la Caixa Junta de Castilla y León Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Insulin-degrading enzyme Insulin clearance Liver Pharmacological inhibitors Insulin resistance |
| topic |
Insulin-degrading enzyme Insulin clearance Liver Pharmacological inhibitors Insulin resistance |
| description |
© 2021 by the authors. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021 2021 2021 2021 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_dcae04bc Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/241744 |
| url |
http://hdl.handle.net/10261/241744 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
#PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2016-77871-C2-2-R info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-110496RB-C22 PID2019-110496RB-C22/AEI/10.13039/501100011033 http://dx.doi.org/10.3390/ijms22052235 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
| publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869420910253965312 |
| score |
15.81155 |